COAPT Continued Access: A Continued Clinical Evaluation of the Safety and Effectiveness of the MitraClip NT System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects
Sponsor: |
Abbott |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAR5218 |
U.S. Govt. ID: |
NCT01626079 |
Contact: |
Lauren Privitera: 212-342-3488 / lp2183@cumc.columbia.edu |
Study for subjects with moderate-to-severe or severe functional mitral regurgitation (MR) and you have been determined to have symptoms due to heart failure despite being treated with currently available therapies, and are not an appropriate candidate for mitral valve surgery.
This study is closed
Investigator
Susheel Kodali, MD
Have you been treated with available therapies and still have symptoms due to heart failure? |
Yes |
No |
Do you have COPD that requires home oxygen therapy or chronic oral steroid use? |
Yes |
No |
Do you have any planned heart surgery in the next 12 months? |
Yes |
No |